Cargando…
The fecal presence of enterotoxin and F4 genes as an indicator of efficacy of treatment with colistin sulfate in pigs
BACKGROUND: Enterotoxigenic Escherichia coli (ETEC) strains producing multiple enterotoxins are important causes of post-weaning diarrhea (PWD) in pigs. The aim of the present study was to investigate the fecal presence of ETEC enterotoxin as well as F4 and F18 genes as an indicator of colistin sulf...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217267/ https://www.ncbi.nlm.nih.gov/pubmed/28056796 http://dx.doi.org/10.1186/s12866-016-0915-0 |
_version_ | 1782492074563600384 |
---|---|
author | Rhouma, Mohamed Fairbrother, John Morris Thériault, William Beaudry, Francis Bergeron, Nadia Laurent-Lewandowski, Sylvette Letellier, Ann |
author_facet | Rhouma, Mohamed Fairbrother, John Morris Thériault, William Beaudry, Francis Bergeron, Nadia Laurent-Lewandowski, Sylvette Letellier, Ann |
author_sort | Rhouma, Mohamed |
collection | PubMed |
description | BACKGROUND: Enterotoxigenic Escherichia coli (ETEC) strains producing multiple enterotoxins are important causes of post-weaning diarrhea (PWD) in pigs. The aim of the present study was to investigate the fecal presence of ETEC enterotoxin as well as F4 and F18 genes as an indicator of colistin sulfate (CS) efficacy for treatment of PWD in pigs. Forty-eight piglets were weaned at the age of 21 days, and were divided into four groups: challenged treated, challenged untreated, unchallenged treated, and unchallenged untreated. Challenge was performed using 10(9) CFU of an ETEC: F4 strain, and treatment was conducted using oral CS at the dose of 50,000 IU/kg. The fecal presence of genes encoding for STa, STb, LT, F4 and F18 was detected using PCR. RESULTS: The PCR amplification of ETEC virulence genes showed that nearly 100% of pigs excreted genes encoding for STa and STb toxins in the feces before the challenge. These genes, in the absence of the gene encoding F4, were considered as a marker for F4-negative ETEC. One day after ETEC: F4 oral challenge pigs in the two challenged groups excreted the genes encoding LT and F4 in the feces. These genes were considered as a marker for F4-positive ETEC. However, the gene encoding F18 was not detected in any fecal samples of the 4 groups throughout the experiment. After only 3 days of successive oral treatment with CS, a significant reduction in both the F4-positive and negative ETEC populations was observed in the challenged treated group compared to the challenged untreated group (p < 0.0001). CONCLUSIONS: Our study is among the first to report that under controlled farming conditions, oral CS treatment had a significant effect on both fecal F4-positive and F4-negative ETEC in pigs. However, CS clinical efficiency was correlated with non-detection of F4-positive ETEC in the feces. Furthermore the fecal presence of F4-negative ETEC was not associated with clinical symptoms of post-weaning diarrhea in pigs. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12866-016-0915-0) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5217267 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-52172672017-01-09 The fecal presence of enterotoxin and F4 genes as an indicator of efficacy of treatment with colistin sulfate in pigs Rhouma, Mohamed Fairbrother, John Morris Thériault, William Beaudry, Francis Bergeron, Nadia Laurent-Lewandowski, Sylvette Letellier, Ann BMC Microbiol Research Article BACKGROUND: Enterotoxigenic Escherichia coli (ETEC) strains producing multiple enterotoxins are important causes of post-weaning diarrhea (PWD) in pigs. The aim of the present study was to investigate the fecal presence of ETEC enterotoxin as well as F4 and F18 genes as an indicator of colistin sulfate (CS) efficacy for treatment of PWD in pigs. Forty-eight piglets were weaned at the age of 21 days, and were divided into four groups: challenged treated, challenged untreated, unchallenged treated, and unchallenged untreated. Challenge was performed using 10(9) CFU of an ETEC: F4 strain, and treatment was conducted using oral CS at the dose of 50,000 IU/kg. The fecal presence of genes encoding for STa, STb, LT, F4 and F18 was detected using PCR. RESULTS: The PCR amplification of ETEC virulence genes showed that nearly 100% of pigs excreted genes encoding for STa and STb toxins in the feces before the challenge. These genes, in the absence of the gene encoding F4, were considered as a marker for F4-negative ETEC. One day after ETEC: F4 oral challenge pigs in the two challenged groups excreted the genes encoding LT and F4 in the feces. These genes were considered as a marker for F4-positive ETEC. However, the gene encoding F18 was not detected in any fecal samples of the 4 groups throughout the experiment. After only 3 days of successive oral treatment with CS, a significant reduction in both the F4-positive and negative ETEC populations was observed in the challenged treated group compared to the challenged untreated group (p < 0.0001). CONCLUSIONS: Our study is among the first to report that under controlled farming conditions, oral CS treatment had a significant effect on both fecal F4-positive and F4-negative ETEC in pigs. However, CS clinical efficiency was correlated with non-detection of F4-positive ETEC in the feces. Furthermore the fecal presence of F4-negative ETEC was not associated with clinical symptoms of post-weaning diarrhea in pigs. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12866-016-0915-0) contains supplementary material, which is available to authorized users. BioMed Central 2017-01-05 /pmc/articles/PMC5217267/ /pubmed/28056796 http://dx.doi.org/10.1186/s12866-016-0915-0 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Rhouma, Mohamed Fairbrother, John Morris Thériault, William Beaudry, Francis Bergeron, Nadia Laurent-Lewandowski, Sylvette Letellier, Ann The fecal presence of enterotoxin and F4 genes as an indicator of efficacy of treatment with colistin sulfate in pigs |
title | The fecal presence of enterotoxin and F4 genes as an indicator of efficacy of treatment with colistin sulfate in pigs |
title_full | The fecal presence of enterotoxin and F4 genes as an indicator of efficacy of treatment with colistin sulfate in pigs |
title_fullStr | The fecal presence of enterotoxin and F4 genes as an indicator of efficacy of treatment with colistin sulfate in pigs |
title_full_unstemmed | The fecal presence of enterotoxin and F4 genes as an indicator of efficacy of treatment with colistin sulfate in pigs |
title_short | The fecal presence of enterotoxin and F4 genes as an indicator of efficacy of treatment with colistin sulfate in pigs |
title_sort | fecal presence of enterotoxin and f4 genes as an indicator of efficacy of treatment with colistin sulfate in pigs |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217267/ https://www.ncbi.nlm.nih.gov/pubmed/28056796 http://dx.doi.org/10.1186/s12866-016-0915-0 |
work_keys_str_mv | AT rhoumamohamed thefecalpresenceofenterotoxinandf4genesasanindicatorofefficacyoftreatmentwithcolistinsulfateinpigs AT fairbrotherjohnmorris thefecalpresenceofenterotoxinandf4genesasanindicatorofefficacyoftreatmentwithcolistinsulfateinpigs AT theriaultwilliam thefecalpresenceofenterotoxinandf4genesasanindicatorofefficacyoftreatmentwithcolistinsulfateinpigs AT beaudryfrancis thefecalpresenceofenterotoxinandf4genesasanindicatorofefficacyoftreatmentwithcolistinsulfateinpigs AT bergeronnadia thefecalpresenceofenterotoxinandf4genesasanindicatorofefficacyoftreatmentwithcolistinsulfateinpigs AT laurentlewandowskisylvette thefecalpresenceofenterotoxinandf4genesasanindicatorofefficacyoftreatmentwithcolistinsulfateinpigs AT letellierann thefecalpresenceofenterotoxinandf4genesasanindicatorofefficacyoftreatmentwithcolistinsulfateinpigs AT rhoumamohamed fecalpresenceofenterotoxinandf4genesasanindicatorofefficacyoftreatmentwithcolistinsulfateinpigs AT fairbrotherjohnmorris fecalpresenceofenterotoxinandf4genesasanindicatorofefficacyoftreatmentwithcolistinsulfateinpigs AT theriaultwilliam fecalpresenceofenterotoxinandf4genesasanindicatorofefficacyoftreatmentwithcolistinsulfateinpigs AT beaudryfrancis fecalpresenceofenterotoxinandf4genesasanindicatorofefficacyoftreatmentwithcolistinsulfateinpigs AT bergeronnadia fecalpresenceofenterotoxinandf4genesasanindicatorofefficacyoftreatmentwithcolistinsulfateinpigs AT laurentlewandowskisylvette fecalpresenceofenterotoxinandf4genesasanindicatorofefficacyoftreatmentwithcolistinsulfateinpigs AT letellierann fecalpresenceofenterotoxinandf4genesasanindicatorofefficacyoftreatmentwithcolistinsulfateinpigs |